Marzetti Q1 sales slightly miss, profit falls on cyclospora outbreak, higher costs
Overview
U.S. specialty food maker's fiscal Q1 sales declined 2.4%, slightly missing analyst expectations
Adjusted EPS for fiscal Q1 fell and missed analyst expectations
Company says cyclospora outbreak and higher costs drove declines in sales and profit
Outlook
Company expects Retail segment sales to benefit from Bachan’s acquisition and new product launches
Company anticipates Foodservice sales to remain supported by select quick-service restaurant customers
Company expects moderate commodity cost inflation and higher diesel and freight costs, to be mitigated by pricing and cost savings
Result Drivers
CYCLOSPORA OUTBREAK - Co said cyclospora outbreak reduced demand and sales for both Retail and Foodservice segments, with estimated 4% decline in Retail and 2% in Foodservice
HIGHER COSTS - Co said significantly higher diesel and freight costs and commissioning costs for new production capacity reduced gross profit and operating income
BACHAN’S ACQUISITION - Newly acquired Bachan’s brand contributed $17.8 mln in incremental Retail segment sales, offsetting some sales decline
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Sales | Slight Miss* | $481.52 mln | $484 mln (5 Analysts) |
Q1 Adjusted EPS | Miss | $1.14 | $1.36 (4 Analysts) |
Q1 Net Income | $29.30 mln |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the food processing peer group is "buy."
Wall Street's median 12-month price target for The Marzetti Company is $135.00, about 21.7% above its November 2 closing price of $110.93
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 15 three months ago
Reuters Recommended Reads
Nov 3 - Taco Bell sales fall more than expected on cyclosporiasis outbreak hit
Nov 3 - Yum Brands tops Q3 adjusted EPS estimates
Nov 3 - Keurig Dr Pepper beats quarterly estimates on steady demand for pricier drinks
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)